Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
Union Minister Jitendra Singh emphasizes the importance of establishing BioE3 Cells in states as interconnected knowledge hubs. These cells will link state and national stakeholders to ensure ...